Changes in ideal cardiovascular health status and risk of new-onset type 2 diabetes The Kailuan prospective study

Medicine (United States)

Volumn 95, Issue 34, 2016, Pages

  Liu, Xiaoxue ^a   Shi, Jihong ^a   Wang, Anxin ^b,c   Song, Qiaofeng ^a   Huang, Zhe ^a   Zhu, Chenrui ^a   Du, Xin ^a   Zhang, Ying ^a   Chen, Shuohua ^a   Wang, Xizhu ^a   Wu, Shouling ^a  

^a NORTH CHINA UNIVERSITY OF SCIENCE AND TECHNOLOGY   (China)

^b CAPITAL MEDICAL UNIVERSITY   (China)

^c CAPITAL MEDICAL UNIVERSITY   (China)

Author keywords

Cardiovascular health status; Diabetes; Hypertension; Improvement; Prospective study

Indexed keywords

GLUCOSE; INSULIN; ORAL ANTIDIABETIC AGENT; C REACTIVE PROTEIN; CHOLESTEROL; GLUCOSE BLOOD LEVEL; SALT INTAKE; TRIACYLGLYCEROL; URIC ACID;

ADULT; ARTICLE; CARDIOVASCULAR HEALTH STATUS; CARDIOVASCULAR RISK; CARDIOVASCULAR SYSTEM EXAMINATION; CHINA; COHORT ANALYSIS; DIABETES MELLITUS; FEMALE; FOLLOW UP; GLUCOSE BLOOD LEVEL; HEALTH STATUS; HUMAN; INSULIN TREATMENT; MAJOR CLINICAL STUDY; MALE; PRIORITY JOURNAL; PROPORTIONAL HAZARDS MODEL; PROSPECTIVE STUDY; RISK ASSESSMENT; BLOOD; BLOOD PRESSURE; BODY MASS; DIABETES MELLITUS, TYPE 2; EXERCISE; HEALTH BEHAVIOR; HEART RATE; INCIDENCE; LIFESTYLE; METABOLISM; MIDDLE AGED; SALT INTAKE; SMOKING;

ADULT; BLOOD GLUCOSE; BLOOD PRESSURE; BODY MASS INDEX; C-REACTIVE PROTEIN; CHINA; CHOLESTEROL; DIABETES MELLITUS, TYPE 2; EXERCISE; FEMALE; HEALTH BEHAVIOR; HEALTH STATUS; HEART RATE; HUMANS; INCIDENCE; LIFE STYLE; MALE; MIDDLE AGED; PROPORTIONAL HAZARDS MODELS; PROSPECTIVE STUDIES; SMOKING; SODIUM CHLORIDE, DIETARY; TRIGLYCERIDES; URIC ACID;

EID: 85011961679     PISSN: 00257974     EISSN: 15365964     Source Type: Journal    
DOI: 10.1097/MD.0000000000004571     Document Type: Article

References (33)

1. Go AS, Mozaffarian D, Roger VL, et al. Executive summary: heart disease and stroke statistics-2013 update: A report from the American Heart Association. Circulation 2013;127:143-52.
2. International Diabetes Federation. IDF Diabetes Atlas. 6th ed. Brussels, Belgium: International Diabetes Federation; 2014. Available at: Www.idf.org/diabetesatlas. Accessed May 3, 2015.
3. Shaw JE, Sicree RA, Zimmet PZ. Global estimates of the prevalence of diabetes for 2010 and 2030. Diabetes Res Clin Pract 2010;87:4-14.
4. Hogan P, Dall T, Nikolov P. Economic costs of diabetes in the US in 2002. Diabetes Care 2003;26:917-32.
5. Narayan KM, Boyle JP, Thompson TJ, et al. Lifetime risk for diabetes mellitus in the United States. JAMA 2003;290:1884-90.
6. Chiasson JL, Josse RG, Gomis R, et al. Acarbose for prevention of type 2 diabetes mellitus: The STOP-NIDDM randomised trial. Lancet 2002;359:2072-7.
7. Knowler WC, Barrett-Connor E, Fowler SE, et al. Reduction in the incidence of type 2 diabetes with lifestyle intervention or metformin. N Engl J Med 2002;346:393-403.
8. Eriksson KF, Lindgarde F. Prevention of type 2 (non-insulin-dependent) diabetes mellitus by diet and physical exercise. The 6-year Malmo feasibility study. Diabetologia 1991;34:891-8.
9. Balk EM, Earley A, Raman G, et al. Combined diet and physical activity promotion programs to prevent type 2 diabetes among persons at increased risk: A systematic review for the Community Preventive Services Task Force. Ann Intern Med 2015;163:437-51.
10. Chan JM, Rimm EB, Colditz GA, et al. Obesity, fat distribution, and weight gain as risk factors for clinical diabetes in men. Diabetes Care 1994;17:961-9.
11. van Dam RM. The epidemiology of lifestyle and risk for type 2 diabetes. Eur J Epidemiol 2003;18:1115-25.
12. Lloyd-Jones DM, Hong Y, Labarthe D, et al. Defining and setting national goals for cardiovascular health promotion and disease reduction: The American Heart Association's strategic Impact Goal through 2020 and beyond. Circulation 2010;121:586-613.
13. Ford ES, Greenlund KJ, Hong Y. Ideal cardiovascular health and mortality from all causes and diseases of the circulatory system among adults in the United States. Circulation 2012;125:987-95.
14. Laitinen TT, Pahkala K, Magnussen CG, et al. Ideal cardiovascular health in childhood and cardiometabolic outcomes in adulthood: The Cardiovascular Risk in Young Finns Study. Circulation 2012;125: 1971-8.
15. Wu S, Huang Z, Yang X, et al. Prevalence of ideal cardiovascular health and its relationship with the 4-year cardiovascular events in a northern Chinese industrial city. Circ Cardiovasc Qual Outcomes 2012;5:487-93.
16. Yang Q, Cogswell ME, Flanders WD, et al. Trends in cardiovascular health metrics and associations with all-cause and CVD mortality among US adults. JAMA 2012;307:1273-83.
17. Rasmussen-Torvik LJ, Shay CM, Abramson JG, et al. Ideal cardiovascular health is inversely associated with incident cancer: The Atherosclerosis Risk in Communities study. Circulation 2013;127:1270-5.
18. Zhang Q, Zhou Y, Gao X, et al. Ideal cardiovascular health metrics and the risks of ischemic and intracerebral hemorrhagic stroke. Stroke 2013;44:2451-6.
19. Kulshreshtha A, Vaccarino V, Judd SE, et al. Life's Simple 7 and risk of incident stroke: The reasons for geographic and racial differences in stroke study. Stroke 2013;44:1909-14.
20. Dong C, Rundek T, Wright CB, et al. Ideal cardiovascular health predicts lower risks of myocardial infarction, stroke, and vascular death across whites, blacks, and Hispanics: The northern Manhattan study. Circulation 2012;125:2975-84.
21. Zhang Y, Tuomilehto J, Jousilahti P, et al. Lifestyle factors on the risks of ischemic and hemorrhagic stroke. Arch Intern Med 2011;171:1811-8.
22. Wang A, Liu X, Guo X, et al. Resting heart rate and risk of hypertension: Results of the Kailuan cohort study. J Hypertens 2014;32:1600-5. [discussion 1605].
23. Wang L, Cui L, Wang Y, et al. Resting heart rate and the risk of developing impaired fasting glucose and diabetes: The Kailuan prospective study. Int J Epidemiol 2015;44:689-99.
24. Bachorik PS, Ross JW. National Cholesterol Education Program recommendations for measurement of low-density lipoprotein cholesterol: Executive summary. The National Cholesterol Education Program Working Group on Lipoprotein Measurement. Clin Chem 1995;41: 1414-20.
25. Expert Committee on the Diagnosis and Classification of Diabetes MellitusReport of the expert committee on the diagnosis and classification of diabetes mellitus. Diabetes Care 2003;26(suppl 1): S5-20.
26. Pan XR, Li GW, Hu YH, et al. Effects of diet and exercise in preventing NIDDM in people with impaired glucose tolerance. The Da Qing IGT and Diabetes Study. Diabetes Care 1997;20:537-44.
27. Hu FB, Manson JE, Stampfer MJ, et al. Diet, lifestyle, and the risk of type 2 diabetes mellitus in women. N Engl J Med 2001;345: 790-7.
28. Effoe VS, Correa A, Chen H, et al. High-sensitivity C-reactive protein is associated with incident type 2 diabetes among African Americans: The Jackson Heart Study. Diabetes Care 2015;38:1694-700.
29. Parrinello CM, Lutsey PL, Ballantyne CM, et al. Six-year change in highsensitivity C-reactive protein and risk of diabetes, cardiovascular disease, and mortality. Am Heart J 2015;170:380-9.
30. Johnson RJ, Merriman T, Lanaspa MA. Causal or noncausal relationship of uric acid with diabetes. Diabetes 2015;64:2720-2.
31. Wijnands JM, Boonen A, van Sloten TT, et al. Association between serum uric acid, aortic, carotid and femoral stiffness among adults aged 40-75 years without and with type 2 diabetes mellitus: The Maastricht Study. J Hypertens 2015;33:1642-50.
32. Liu Y, Chi HJ, Cui LF, et al. The ideal cardiovascular health metrics associated inversely with mortality from all causes and from cardiovascular diseases among adults in a Northern Chinese industrial city. PLoS One 2014;9:e89161.
33. Zhang Q, Zhang S, Wang C, et al. Ideal cardiovascular health metrics on the prevalence of asymptomatic intracranial artery stenosis: A crosssectional study. PLoS One 2013;8:e58923.